Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein

被引：48

作者：

Wang, Lin ^{[1
,2
]}

Wu, Yan ^{[3
]}

Yao, Sheng ^{[4
,5
]}

Ge, Huan ^{[6
]}

Zhu, Ya ^{[7
]}

Chen, Kun ^{[7
]}

Chen, Wen-zhang ^{[1
]}

Zhang, Yi ^{[1
]}

Zhu, Wei ^{[1
]}

Wang, Hong-yang ^{[2
]}

Guo, Yu ^{[8
,9
]}

Ma, Pei-xiang ^{[1
]}

Ren, Peng-xuan ^{[1
,2
]}

Zhang, Xiang-lei ^{[1
,2
]}

Li, Hui-qiong ^{[1
,2
]}

Ali, Mohammad A. ^{[10
]}

Xu, Wen-qing ^{[2
]}

Jiang, Hua-liang ^{[1
,7
]}

Zhang, Lei-ke ^{[3
]}

Zhu, Li-li ^{[2
,6
]}

Ye, Yang ^{[4
,5
]}

Shang, Wei-juan ^{[3
]}

Bai, Fang ^{[1
,2
]}

机构：

[1] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China

[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China

[3] Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, State Key Lab Virol, Wuhan 430064, Peoples R China

[4] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Nat Prod Chem, Shanghai 201203, Peoples R China

[5] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China

[6] East China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China

[7] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China

[8] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China

[9] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China

[10] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia

来源：

ACTA PHARMACOLOGICA SINICA | 2022年 / 43卷 / 04期

基金：

中国国家自然科学基金; 上海市科技启明星计划;

关键词：

SARS-CoV-2; natural products; virtual screening; spike protein; protein-protein interaction modulators; INHIBITORS; BINDING; DOCKING; ACE2;

D O I：

10.1038/s41401-021-00735-z

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

An epidemic of pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. SARS-CoV-2 relies on its spike protein to invade host cells by interacting with the human receptor protein Angiotensin-Converting Enzymes 2 (ACE2). Therefore, designing an antibody or small-molecular entry blockers is of great significance for virus prevention and treatment. This study identified five potential small molecular anti-virus blockers via targeting SARS-CoV-2 spike protein by combining in silico technologies with in vitro experimental methods. The five molecules were natural products that binding to the RBD domain of SARS-CoV-2 was qualitatively and quantitively validated by both native Mass Spectrometry (MS) and Surface Plasmon Resonance (SPR). Anti-viral activity assays showed that the optimal molecule, H69C2, had a strong binding affinity (dissociation constant K-D) of 0.0947 mu M and anti-virus IC50 of 85.75 mu M.

引用

页码：788 / 796

页数：9

共 50 条

[1] Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Lin Wang
Yan Wu
Sheng Yao
Huan Ge
Ya Zhu
Kun Chen
Wen-zhang Chen
Yi Zhang
Wei Zhu
Hong-yang Wang
Yu Guo
Pei-xiang Ma
Peng-xuan Ren
Xiang-lei Zhang
Hui-qiong Li
Mohammad A. Ali
Wen-qing Xu
Hua-liang Jiang
Lei-ke Zhang
Li-li Zhu
Yang Ye
Wei-juan Shang
Fang Bai
Acta Pharmacologica Sinica, 2022, 43 : 788 - 796
[2] Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
Hu, Xin
Chen, Catherine Z.
Xu, Miao
Hu, Zongyi
Guo, Hui
Itkin, Zina
Shinn, Paul
Ivin, Parker
Leek, Madeleine
Liang, T. Jake
Shen, Min
Zheng, Wei
Hall, Matthew D.
ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (08): : 1267 - 1274
[3] Discovery of small molecule entry inhibitors targeting the linoleic acid binding pocket of SARS-CoV-2 spike protein
Prasad, Roshny
Kadam, Anil
Padippurackal, Vinitha Vinod
Pulikuttymadom Balasubramanian, Aparna
Kumar Chandrakumaran, Naveen
Suresh Rangari, Kartik
Dnyaneshwar Khangar, Pawan
Ajith, Harikrishnan
Natarajan, Kathiresan
Chandramohanadas, Rajesh
Nelson-Sathi, Shijulal
CURRENT SCIENCE, 2024, 126 (09):
[4] Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
Liang, Taizhen
Xiao, Shiqi
Wu, Ziyao
Lv, Xi
Liu, Sen
Hu, Meilin
Li, Guojie
Li, Peiwen
Ma, Xiancai
VIRUSES-BASEL, 2023, 15 (08):
[5] Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
Chen, Yuliu
Wu, Yan
Chen, Shaoying
Zhan, Qingping
Wu, Dingzhou
Yang, Chan
He, Xiaoxue
Qiu, Mengjie
Zhang, Nannan
Li, Zhaofeng
Guo, Yunhua
Wen, Minjun
Lu, Lu
Ma, Cuiqing
Guo, Jiayin
Xu, Wei
Li, Xiaojuan
Li, Lin
Jiang, Shibo
Pan, Xiaoyan
Liu, Shuwen
Tan, Suiyi
JOURNAL OF VIROLOGY, 2022, 96 (24)
[6] Potential antiviral peptides targeting the SARS-CoV-2 spike protein
Khater, Ibrahim
Nassar, Aaya
BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
[7] Potential antiviral peptides targeting the SARS-CoV-2 spike protein
Ibrahim Khater
Aaya Nassar
BMC Pharmacology and Toxicology, 23
[8] In Silico Discovery of Small Molecule Modulators Targeting the Achilles' Heel of SARS-CoV-2 Spike Protein
Wang, Qing
Meng, Fanhao
Xie, Yuting
Wang, Wei
Meng, Yumin
Li, Linjie
Liu, Tao
Qi, Jianxun
Ni, Xiaodan
Zheng, Sanduo
Huang, Jianhui
Huang, Niu
ACS CENTRAL SCIENCE, 2023,
[9] Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry
Guseman, Alex
Rennick, Linda
Nambulli, Sham
Bhinderwhala, Fatema
Martinez, David
Baric, Ralph
Duprex, Paul
Gronenborn, Angela
JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S388 - S388
[10] Neutralizing antibodies targeting SARS-CoV-2 spike protein
Shi Xiaojie
Li Yu
Yan Lei
Yang Guang
Qiang Min
STEM CELL RESEARCH, 2021, 50

← 1 2 3 4 5 →